<

 
Data updated 2025-05-08 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date18201976.0 (espacenet)  (Federated)  (European Patent Register), 20080108
Patent/reg. no. and dateDK/EP 3456340, 20220216
Publication date20190320
Priority no. and dateUS 87903307 P, 20070108
EP pub. no. and date EP 3456340 20190320
Effective date
Applicant/ownerThe Trustees of the
University of Pennsylvania, 3160 Chestnut Street,
Suite 200
Philadelphia, PA 19104-6283, US,
Children's Hospital of Philadelphia, 3401 Civic Center Boulevard
Philadelphia, PA 19104, US
Applicant ref. no.BBS184240EPDK
InventorSTOFFERS, Doris, 3 Rosewood Lane
Moorestown, NJ New Jersey 08057, US,
DE LEON, Diva D, 429 Sprague Rd
Penn Valley, PA Pennsylvania 19072, US,
STANLEY, Charles, 503 Penn Avenue
Drexel Hil, PA Pennsylvania 19026, US
RepresentativeNovagraaf Brevets, Bâtiment O2, 2 rue Sarah Bernhardt CS90017 F-92665 Asnières-sur-Seine cedex, FR
Opponent
IPC ClassA61K 38/26 (2006.01) , A61P 3/10 (2006.01) 
TitleGLP-1-RECEPTORANTAGONIST TIL BRUG VED BEHANDLING AF MEDFØDT HYPERINSULISME
Int. application no.
Int. publication no.
Related patent (certificate)
StatusDK/EP patent
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact